Company intelligence / Profile preview

Ovulai

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Ovulai developed Sweden's first digital PCOS management app, offering evidence-based education, symptom tracking, and individualized health programs to women diagnosed with polycystic ovary syndrome. The company was acquired by EsterCare, allowing its users to access PCOS care within a broader digital women’s health platform.

Therapeutic areas: Endocrinology
Modalities: Non-pharmacological therapyDevice (mobile app)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Ovulai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovulai.

Explore the full profile